Technology Interventions for Youth Alcohol Use
Comparing Scalable Technology-Driven Brief Intervention Packages for Youth Alcohol Use
University of Michigan
1,400 participants
Oct 25, 2023
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate the effects of two programs to prevent/reduce alcohol misuse among youth primary care patients. Depending on their study condition, youth will receive a brief web-based computer program or the web program + 8 weeks of supportive text messages. Parents/caregivers of youth are encouraged to use a freely available app to guide conversations with their child about drinking. This study will have significant impact by evaluating response to these scalable interventions which can be deployed widely in clinical care settings.
Eligibility
Inclusion Criteria3
- patients age 12-19 within the Michigan Medicine health system who had a visit within the past 2 years; and
- past 12-month alcohol use; and
- patient has a phone that can receive text messages
Exclusion Criteria5
- patients who do not understand English; or
- patients deemed unable to provide informed consent due to conditions that preclude understanding of assessment or intervention content; or
- parent/guardian consent is not obtained; or
- another child in household already enrolled in the study; or
- ongoing participation in another behavioral health research study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Youth receive a brief interactive web program made available online to prevent alcohol misuse. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.
Youth receive a brief interactive web program made available online to prevent alcohol misuse. This is followed by 8 weeks of supportive text messages. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05988931